Understanding the AMCP dossier format: A practical guide to US payer decision-making
Securing formulary access depends on giving US payers actionable evidence and insights. But AMCP dossier format requirements are getting more rigorous, and expectations keep shifting. Learn exactly how to build a compliant, payer-ready dossier with this practical guide to the AMCP dossier purpose, structure, and best practices.
Why this guide is a must-have:
- Explains the AMCP dossier format and how it supports US formulary and reimbursement decisions
- Clarifies the AMCP dossier purpose for payers, from P&T committees to PBMs
- Provides best practice steps for building dossiers aligned with current AMCP dossier guidelines
- Shows how to avoid the most common dossier development failures
Key failures that jeopardize favorable decision-making in AMCP dossier development:
❌ Raw data that is poorly linked to relevant payer priorities, such as comparative value and budget impact
❌ Evidence buried across clinical reports, HEOR models, and internal analyses, causing inconsistency and slow compilation
❌ Cross-functional misalignment: lack of shared ownership across HEOR, medical affairs, and market access (causing inconsistent messaging and delays)
What you’ll learn with our AMCP dossier guidelines:
- How the AMCP dossier format organizes clinical, economic, and safety evidence for US payer decision-making
- The key differences between an AMCP dossier and a Global Value Dossier (GVD):
- whether you need both
- How to comply with the current Version 5.0 AMCP dossier format
- Evolving payer expectations:
- how the upcoming AMCP dossier format Version 6.0 is reshaping requirements
- Common failure points and traps teams fall into when developing dossiers
- Best practices steps and field-tested approaches for building a dossier that’s clear, credible, and aligned to payer decision-making
Submit the form now to download your copy of this AMCP dossier guide and start building submissions that gain favorable outcomes ➡️
